BioSpace News Archive

Global Plasma Solutions, the leader in Indoor Air Quality, announced today industry-leading ionization testing results, demonstrating a 99.4% reduction rate on a SARS-CoV-2 (COVID-19) surface strain within 30 minutes, the first instance in which an air purification company has effectively neutralized SARS-CoV-2.

Samsung announced today the immediate availability of the RS85 Prestige, the latest addition to the company’s portfolio of ultrasound systems.

Jesse’s Journey, Canada’s leader in Duchenne muscular dystrophy funded research, is proud to announce a $1M grant towards a clinical trial evaluating vamorolone in children and adolescents living with Duchenne, the most common fatal genetic disease diagnosed in childhood.

Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock in an underwritten public offering

Catalent, Inc., the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene therapies, and consumer health products, announced that it has launched an underwritten public offering of $550 million of its common stock.

Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming anemia management and improving outcomes for patients around the world, today announced the appointment of industry leader and renowned authority on kidney disease, Allen R. Nissenson, M.D., F.A.C.P., to its Board of Directors

Believes that Change is Needed at Volition – Including Resignation of CEO Cameron Reynolds and Formation of Strategy Committee Comprised of New Directors

Twenty One Additional Self-Swab Testing Sites to Open Across Michigan, New Hampshire, New Jersey, New York, Ohio, Pennsylvania and Virginia

Joint Program Launched by Reagan-Udall Foundation for the FDA and Friends of Cancer Research Delivers Real World Understanding of COVID-19

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Understanding with Cannomed Medical Cannabis Industries Ltd. (TASE: CNMD), to develop cannabis cultivars targeted to treat c